Overview
At a Glance
PRP (Platelet-Rich Plasma) and PRF (Platelet-Rich Fibrin) are autologous blood concentrates — meaning they are derived from the patient's own blood. A small blood draw is centrifuged to concentrate platelets and growth factors, which are then re-injected or applied to the treatment area. These treatments are used in dermatology, hair restoration, orthopedics, and dentistry. PRP has been studied since the 1990s; PRF is a newer evolution that retains a fibrin matrix for slower, sustained growth factor release. Typical costs range from $500 to $1,500 per session, and most patients require multiple sessions.Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) therapies harness the body's own healing mechanisms by concentrating platelets, growth factors, and bioactive proteins from a patient's blood and delivering them directly to a treatment site. The core principle is straightforward: platelets are the body's first responders to tissue injury, releasing a cascade of growth factors that initiate and coordinate the healing process. By concentrating these platelets to levels 3–8 times above baseline and delivering them precisely where they are needed, clinicians aim to accelerate and enhance natural tissue repair.
PRP was first described in the hematology literature in the 1970s, but its clinical application expanded significantly in the 1990s and 2000s, particularly in oral and maxillofacial surgery. PRF, developed by Choukroun and colleagues in 2001, represented a second-generation approach that simplified preparation and produced a fibrin scaffold capable of sustained growth factor release over 7–14 days (Choukroun et al., 2006).
The growth factors concentrated in PRP and PRF include platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and insulin-like growth factor (IGF-1). These collectively stimulate collagen synthesis, angiogenesis, cell proliferation, and extracellular matrix remodeling — the fundamental processes of tissue repair and regeneration.
Clinical applications have expanded to include skin rejuvenation, hair loss treatment (androgenetic alopecia), osteoarthritis, tendinopathy, chronic wound healing, and dental/oral surgery. The evidence base varies by application: hair restoration and knee osteoarthritis have the most robust clinical trial data, while facial rejuvenation evidence is growing but still developing.
Quick Facts
| Property | Details |
|---|---|
| Source material | Patient's own venous blood (autologous) |
| Blood draw | Typically 10–60 mL depending on application |
| Platelet concentration | 3–8× baseline (PRP); 1.5–3× baseline (PRF) |
| Key growth factors | PDGF, TGF-β, VEGF, EGF, IGF-1 |
| Procedure time | 30–60 minutes including blood draw and preparation |
| Downtime | Minimal to none for injections; 1–3 days for microneedling applications |
| Sessions needed | Typically 3–4 sessions spaced 4–6 weeks apart |
| FDA status | Devices (centrifuges/kits) are FDA-cleared; the procedure itself is not FDA-regulated |
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
How It Works
The Platelet Healing Cascade
Platelets are small, anucleate blood cells primarily known for their role in hemostasis (blood clotting). However, platelets also contain alpha granules packed with growth factors, cytokines, and bioactive proteins that are released upon activation. In normal wound healing, platelets are among the first cells to arrive at an injury site, where they form a clot and release their growth factor payload to recruit repair cells and initiate tissue regeneration.
The key growth factors released by activated platelets include:
- PDGF (Platelet-Derived Growth Factor): Stimulates cell replication, angiogenesis, and collagen synthesis. Recruits mesenchymal stem cells to the injury site (Marx, 2004).
- TGF-β (Transforming Growth Factor-Beta): Promotes extracellular matrix production, regulates immune cell activity, and stimulates fibroblast and osteoblast differentiation.
- VEGF (Vascular Endothelial Growth Factor): Drives new blood vessel formation (angiogenesis), critical for delivering oxygen and nutrients to healing tissues.
- EGF (Epidermal Growth Factor): Stimulates epithelial cell growth, differentiation, and wound re-epithelialization.
- IGF-1 (Insulin-Like Growth Factor-1): Promotes cell growth and differentiation; mediates many of the anabolic effects of growth hormone in tissues.
- FGF (Fibroblast Growth Factor): Stimulates fibroblast proliferation and angiogenesis; important for connective tissue repair.
PRP Preparation
The standard PRP preparation protocol involves:
- Blood draw: 10–60 mL of venous blood is collected into tubes containing an anticoagulant (typically sodium citrate or ACD-A).
- Centrifugation: The blood is spun in a centrifuge, separating it into layers by density — red blood cells (heaviest) settle at the bottom, a "buffy coat" of platelets and white blood cells forms in the middle, and platelet-poor plasma rises to the top.
- Collection: The platelet-rich layer is carefully aspirated, producing a concentrate with 3–8 times the baseline platelet count.
- Activation (optional): Some protocols activate platelets before injection using calcium chloride or thrombin, triggering immediate growth factor release. Others inject PRP in its non-activated form, relying on tissue collagen to trigger activation in vivo.
PRF Preparation
PRF preparation differs from PRP in several important ways:
- No anticoagulant: Blood is collected without anticoagulant, allowing natural fibrin polymerization to begin immediately.
- Lower centrifugation speed: PRF uses slower centrifugation speeds (relative centrifugal force of ~200–700g vs. 1,000–3,000g for PRP), which preserves more white blood cells and produces a denser fibrin matrix.
- Fibrin scaffold: The result is a three-dimensional fibrin matrix that physically traps platelets, leukocytes, and growth factors within its structure. This matrix serves as a scaffold for cell migration and provides sustained growth factor release over 7–14 days, compared to the rapid bolus release from activated PRP (Choukroun et al., 2006).
Injectable PRF (i-PRF) and EZ Gel PRF
Injectable PRF (i-PRF) is a liquid form of PRF collected before the fibrin matrix fully polymerizes. It can be injected like PRP but retains the leukocyte-rich composition and slower growth factor release profile of PRF. EZ Gel PRF represents a further evolution: the i-PRF is combined with heat-treated albumin from the patient's own blood to create a gel-like injectable that functions as both a growth factor delivery system and a volumizing filler. EZ Gel has gained attention as a natural, autologous alternative to synthetic dermal fillers, though long-term data on its volumizing durability is limited.
Mechanism at the Tissue Level
Once delivered to the target tissue, PRP/PRF initiates a coordinated healing response:
- Inflammation modulation: Growth factors attract macrophages and other immune cells that clear damaged tissue and debris.
- Cell proliferation: Fibroblasts, keratinocytes, and endothelial cells are stimulated to multiply, providing the cellular building blocks for repair.
- Collagen synthesis: Fibroblasts produce new collagen (primarily types I and III), strengthening and restructuring the treated tissue.
- Angiogenesis: VEGF and FGF drive new blood vessel formation, improving tissue perfusion and oxygen delivery.
- Matrix remodeling: Over weeks to months, the initial repair tissue is remodeled into more organized, functional tissue (Dhurat & Sukesh, 2014).
Go Deeper
- Marx (2004) — "Platelet-Rich Plasma: Evidence to Support Its Use" — Journal of Oral and Maxillofacial Surgery
- Choukroun et al. (2006) — "PRF: A second-generation platelet concentrate" — Oral Surgery, Oral Medicine, Oral Pathology
- Dhurat & Sukesh (2014) — "Principles and Methods of Preparation of PRP" — Indian Journal of Dermatology
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
PRP vs PRF
At a Glance
The key practical differences between PRP and PRF — preparation, what you get, and what it costs.
| Feature | PRP | PRF |
|---|---|---|
| In plain terms | Your blood is drawn, spun fast in a centrifuge, and the platelet-rich liquid is injected back into the treatment area | Same blood draw, but spun slower with no additives — produces a gel-like clot that releases growth factors gradually over 1–2 weeks |
| How it works | Delivers a concentrated burst of growth factors immediately upon injection | The fibrin scaffold slowly releases growth factors over 7–14 days — more sustained delivery |
| Best studied for | Hair loss, knee osteoarthritis, skin rejuvenation, tendon injuries | Facial rejuvenation, hair loss, dental/oral surgery, wound healing |
| Evidence | ✓✓✓ Larger evidence base — multiple randomized controlled trials across applications | ✓✓ Growing evidence — fewer but promising clinical studies; well-established in dental surgery |
| Sessions needed | Typically 3–4 sessions, 4–6 weeks apart | Typically 3–4 sessions, 4–6 weeks apart (similar to PRP) |
| Downtime | Minimal — redness, swelling for 1–3 days | Minimal — similar to PRP |
| Cost per session | $500–$1,500 | $500–$1,500 (comparable) |
Looking for more detail? The scientific comparison below breaks down the technical differences — preparation protocols, platelet concentrations, growth factor kinetics, and sourced references.
Head-to-Head Scientific Comparison
| Feature | PRP | PRF |
|---|---|---|
| Anticoagulant | Yes (sodium citrate or ACD-A) | No |
| Centrifuge speed | Higher (1,000–3,000g) | Lower (200–700g) |
| Platelet concentration | 3–8× baseline | 1.5–3× baseline |
| White blood cells | Varies by protocol (LR-PRP includes; LP-PRP excludes) | Retained in fibrin matrix |
| Fibrin matrix | None (liquid) | Yes — three-dimensional scaffold |
| Growth factor release | Rapid bolus (hours) | Sustained release (7–14 days) |
| Form | Liquid (injectable) | Membrane/clot (solid PRF) or liquid (i-PRF) |
| Additives | Optional activation (CaCl₂, thrombin) | None required |
| Preparation time | 15–20 minutes | 10–15 minutes |
| Cost | Similar | Similar (may be slightly less due to simpler preparation) |
Generations of Platelet Concentrates
Platelet concentrate technology has evolved through several generations:
- First generation — PRP: Liquid platelet concentrate requiring anticoagulant. High platelet counts but rapid growth factor release. Requires activation for optimal growth factor delivery.
- Second generation — L-PRF (Choukroun PRF): Solid fibrin membrane with embedded platelets and leukocytes. No additives needed. Used primarily in oral and maxillofacial surgery as a membrane or plug (Choukroun et al., 2006).
- Third generation — i-PRF / A-PRF: Injectable PRF (liquid collected before polymerization) and Advanced PRF (modified centrifugation protocols for higher cell concentrations). Expanded applications in aesthetics and orthopedics.
- EZ Gel PRF: i-PRF combined with heat-treated autologous albumin to create a gel-like filler with both regenerative and volumizing properties.
Which Is Better?
The question of whether PRP or PRF is "better" does not have a universal answer — it depends on the application:
- Hair restoration: Both have shown efficacy. PRP has more published clinical trial data. PRF's sustained release may offer theoretical advantages for follicle stimulation, but head-to-head trials are limited.
- Skin rejuvenation: PRF and EZ Gel PRF are gaining preference among some dermatologists for facial applications due to sustained growth factor release and the potential volumizing effect of EZ Gel.
- Orthopedic applications: PRP has the larger evidence base for osteoarthritis and tendinopathy. Leukocyte-rich PRP (LR-PRP) appears to be more effective for tendinopathy, while leukocyte-poor PRP (LP-PRP) may be preferred for intra-articular knee injections (Riboh et al., 2016).
- Oral/dental surgery: L-PRF membranes are widely used in socket preservation, sinus lifts, and bone grafting procedures, where the solid fibrin scaffold provides a physical matrix for healing.
Further Reading
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Skin Rejuvenation
The "Vampire Facial"
PRP facial rejuvenation — popularly known as the "Vampire Facial" — involves applying PRP to the face, typically in combination with microneedling. Microneedling creates controlled micro-channels in the skin that serve dual purposes: they trigger the skin's wound-healing response and allow PRP to penetrate beyond the stratum corneum into the deeper dermis where it can interact directly with fibroblasts and other target cells.
The procedure typically involves:
- Blood draw (10–20 mL)
- Centrifugation and PRP/PRF preparation
- Topical anesthetic application (20–30 minutes)
- Microneedling of the treatment area with PRP applied topically
- Additional PRP injected into specific areas (nasolabial folds, under-eye hollows, fine lines) as needed
What the Research Shows
A systematic review by Hersant et al. evaluated PRP for facial rejuvenation and found that PRP-treated patients showed statistically significant improvements in skin texture, tone, and wrinkle depth compared to controls. The review noted that combination therapy (PRP + microneedling or PRP + hyaluronic acid) produced superior results to PRP alone (Hersant et al., 2021).
Additional findings from the dermatology literature:
- Collagen stimulation: Histological studies show increased collagen type I and III deposition in PRP-treated skin, with improvements detectable 2–3 months after treatment.
- Acne scarring: PRP combined with microneedling has shown improvement in atrophic acne scars in multiple randomized controlled trials, with results comparable to or better than microneedling alone.
- Under-eye rejuvenation: PRP injections for periorbital dark circles and hollowing have shown modest improvements, though evidence is limited to small studies.
- Skin texture and tone: Patients commonly report improved skin luminosity, reduced pore size appearance, and more even skin tone following a series of PRP treatments.
EZ Gel PRF for Facial Volume
EZ Gel PRF has emerged as an autologous alternative to synthetic hyaluronic acid fillers for facial volumization. By combining i-PRF with heat-treated albumin from the patient's own blood, EZ Gel creates a biocompatible gel that provides both immediate volume and sustained growth factor release. Reported applications include nasolabial fold correction, cheek volume restoration, and under-eye hollowing. Because EZ Gel is entirely autologous, the risk of allergic reaction or granuloma formation associated with synthetic fillers is eliminated. However, volumizing duration is shorter than synthetic fillers (typically 3–6 months vs. 6–18 months for HA fillers), and long-term efficacy data is limited.
Treatment Protocol
| Parameter | Typical Protocol |
|---|---|
| Sessions | 3–4 sessions, spaced 4–6 weeks apart |
| Maintenance | 1–2 sessions per year after initial series |
| Results onset | Initial glow within days; collagen improvements over 2–3 months |
| Peak results | 3–6 months after final session |
| Downtime | Redness and mild swelling for 1–3 days (microneedling); minimal for injection only |
Further Reading
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Hair Restoration
Evidence for Hair Loss Treatment
PRP for hair loss has a growing evidence base with several important studies:
- Gentile et al. (2015): A randomized, blinded, half-head trial in patients with androgenetic alopecia. PRP-treated areas showed a statistically significant increase in hair count and hair density (mean increase of 33.6 hairs per cm²) compared to placebo-treated areas at 3 months. Histological analysis confirmed increased follicle size and density of terminal hairs in PRP-treated scalp (Gentile et al., 2015).
- Leo et al. (2015): A prospective study evaluating PRP for androgenetic alopecia that demonstrated increased hair shaft diameter, hair density per cm², and improvement on the pull test at 3 and 6 months after PRP treatment. Dermatoscopic evaluation confirmed new hair growth and increased anagen (active growth phase) hairs (Leo et al., 2015).
- Systematic reviews and meta-analyses: Multiple systematic reviews have concluded that PRP shows statistically significant improvements in hair density and thickness compared to placebo, though the optimal preparation protocol, concentration, and treatment schedule remain to be standardized.
How PRP Promotes Hair Growth
PRP is proposed to stimulate hair growth through several mechanisms:
- Dermal papilla stimulation: Growth factors (particularly PDGF and VEGF) stimulate dermal papilla cells — the specialized mesenchymal cells at the base of each hair follicle that regulate the hair growth cycle.
- Anagen prolongation: PRP appears to prolong the anagen (active growth) phase of the hair cycle while potentially shortening the catagen (regression) phase, resulting in longer, thicker hairs.
- Perifollicular angiogenesis: VEGF promotes new blood vessel formation around hair follicles, improving nutrient and oxygen delivery to the follicular unit.
- Anti-apoptotic effects: PRP growth factors may protect follicular cells from programmed cell death, preserving follicles that would otherwise miniaturize and eventually stop producing visible hair (Gentile et al., 2015).
Treatment Protocol for Hair Loss
| Parameter | Typical Protocol |
|---|---|
| Blood draw | 20–60 mL |
| Injection technique | Multiple small injections (0.05–0.1 mL each) across the affected scalp area, approximately 1 cm apart |
| Depth | Intradermal to dermal papilla level (~3–5 mm) |
| Initial series | 3–4 sessions, spaced 4 weeks apart |
| Maintenance | Every 6–12 months |
| Results onset | Reduced shedding within weeks; visible new growth at 2–3 months |
| Peak results | 6–12 months after initial series |
| Best candidates | Early to moderate hair loss (Norwood II–V; Ludwig I–II). Miniaturized but still-present follicles respond better than completely bald areas. |
Limitations
- PRP does not regrow hair from follicles that have been completely lost (scarred or fully atrophied).
- Results are most pronounced in early-to-moderate hair loss where miniaturized follicles can still be rescued.
- PRP is not a replacement for FDA-approved hair loss treatments (finasteride, minoxidil); it is most commonly used as an adjunct.
- Standardization remains a challenge — different PRP preparation protocols, platelet concentrations, and injection techniques make study comparison difficult.
- Maintenance treatments are required; results regress without ongoing sessions.
Further Reading
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Orthopedic Uses
Knee Osteoarthritis
Knee osteoarthritis is the most extensively studied orthopedic application of PRP. Meta-analyses of randomized controlled trials have consistently shown that PRP injections provide greater pain relief and functional improvement compared to hyaluronic acid, corticosteroid, or saline injections at follow-up periods of 6–12 months.
Key findings from the literature:
- PRP injections reduced WOMAC (Western Ontario and McMaster Universities Arthritis Index) pain scores significantly more than hyaluronic acid at 6 and 12 months.
- Leukocyte-poor PRP (LP-PRP) appears to be preferred for intra-articular knee injections, as it produces less inflammatory reaction in the joint capsule compared to leukocyte-rich PRP (Riboh et al., 2016).
- Best results are seen in patients with mild-to-moderate osteoarthritis (Kellgren-Lawrence grade I–III); advanced bone-on-bone arthritis (grade IV) shows less benefit.
- A typical protocol involves 1–3 injections spaced 2–4 weeks apart, with effects lasting 6–12 months before repeat treatment is needed.
Tendinopathy
- Lateral epicondylitis (tennis elbow): PRP has shown positive results in chronic lateral epicondylitis refractory to conservative treatment, with improvements in pain and grip strength at 6–12 months (Mishra & Pavelko, 2006).
- Patellar tendinopathy (jumper's knee): PRP injections have shown improvement in chronic patellar tendinopathy, particularly in cases that have not responded to eccentric exercise protocols.
- Achilles tendinopathy: Results are mixed; some studies show benefit while others show no significant difference from placebo. The variability may relate to differences in PRP preparation protocols.
- Rotator cuff tendinopathy: PRP as an adjunct to rotator cuff repair has shown improved healing rates in some studies, though results are not uniformly positive.
Muscle Injuries
PRP has been investigated for acute muscle injuries (strains, tears) in athletic populations. Some studies suggest faster return-to-sport timelines with PRP injection at the injury site, though the evidence is not conclusive enough to establish PRP as standard of care for muscle injuries.
Further Reading
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Side Effects
Common Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Injection-site pain | Common | Mild to moderate pain at the injection site, typically lasting 24–72 hours. More pronounced with scalp injections and intra-articular injections. |
| Swelling | Common | Localized swelling at the treatment area, resolving within 1–3 days. Expected with facial treatments. |
| Bruising | Common | Ecchymosis at injection sites, particularly in the face and scalp. Resolves within 5–10 days. |
| Redness/erythema | Common | Skin redness at treatment site, especially with microneedling. Resolves within 24–48 hours. |
| Headache | Uncommon | More commonly reported after scalp PRP injections for hair loss. |
| Temporary hair shedding | Uncommon | "Shock shedding" reported by some hair-loss patients in the first 2–4 weeks; typically resolves with subsequent regrowth. |
| Joint stiffness/flare | Uncommon | Temporary increase in joint pain or stiffness after intra-articular PRP, usually lasting 24–48 hours. More common with leukocyte-rich PRP. |
| Infection | Rare | As with any injection procedure, infection is possible. Sterile technique minimizes this risk. |
What PRP/PRF Does NOT Cause
Because PRP and PRF are autologous (from the patient's own blood):
- No allergic reactions to the product itself (though reactions to local anesthetics or antiseptics used during the procedure are possible).
- No immune rejection.
- No disease transmission from the platelet concentrate (the blood is the patient's own — see Safety tab for cross-contamination risks from poor clinic practices).
- No systemic toxicity — the volumes used are small and the growth factors are physiological.
Contraindications
- Active infection at the treatment site
- Blood disorders: Thrombocytopenia, platelet dysfunction syndromes, critical anemia
- Anticoagulation therapy: Relative contraindication; some providers proceed with caution
- Active cancer: Theoretical concern that growth factors could promote tumor growth (similar to any angiogenic therapy)
- Pregnancy and breastfeeding: Insufficient safety data
- Sepsis or systemic infection
Further Reading
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Safety Concerns
The 2019 "Vampire Facial" HIV Case
In 2019, the CDC and New Mexico Department of Health investigated HIV transmission linked to "Vampire Facial" procedures performed at VIP Spa in Albuquerque, New Mexico. The investigation identified at least two clients who acquired HIV infection likely through cross-contamination during PRP facial procedures. The facility was unlicensed, and inspectors documented multiple infection-control failures including reuse of equipment intended for single use, inadequate sterilization, and improper blood-handling practices (CDC MMWR, 2020).
The VIP Spa case is significant not because PRP is inherently dangerous — it is not — but because it exposed what can happen when blood-based procedures are performed in unregulated settings without proper infection control. The HIV transmission occurred through cross-contamination between clients' blood, not through the PRP itself. The same contamination risk would exist with any procedure involving blood (injections, blood draws, IV infusions) if performed with reused or improperly sterilized equipment.
Lessons from the VIP Spa Case
- Licensing matters: The facility was not licensed to perform medical procedures involving blood. Always verify that your provider is licensed and that the facility is properly accredited.
- Single-use equipment: All needles, syringes, blood collection tubes, and centrifuge accessories must be single-use and disposed of after each patient.
- Blood handling protocols: Universal precautions for blood-borne pathogen prevention must be followed. This includes proper labeling of each patient's blood products to prevent mix-ups.
- Provider qualifications: PRP/PRF procedures should be performed by or under the supervision of licensed healthcare providers (physicians, nurse practitioners, physician assistants) trained in sterile technique and blood handling.
How to Verify Clinic Safety
Patients considering PRP/PRF treatments should verify:
- The provider holds a valid medical license in the state where they practice.
- The facility is inspected and accredited (by state health department or a recognized accreditation body).
- All equipment is opened from sealed, single-use packaging in front of the patient.
- Blood collection tubes are labeled with the patient's name immediately after the draw.
- The centrifuge and preparation area are clean, and universal precautions are visibly practiced.
- The provider can explain the preparation process and answer questions about infection control.
Autologous vs. Allogeneic Safety
PRP and PRF are autologous — derived from the patient's own blood. This eliminates the disease-transmission and immune-rejection risks associated with allogeneic (donor-derived) blood products. The safety advantage of autologous therapy is significant: there is no risk of blood-type incompatibility, transfusion reaction, or donor-transmitted infection from the product itself. The only infection risk comes from the procedure (non-sterile technique, cross-contamination) rather than from the biologic material.
Further Reading
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Regulatory Status
FDA's Role: Devices, Not the Procedure
The FDA's regulatory framework for PRP/PRF focuses on the medical devices used in preparation rather than the procedure itself:
- Centrifuges and preparation kits: FDA-cleared as Class II or Class III medical devices. These devices must meet FDA standards for safety and performance. Examples include the Harvest SmartPrep, Arthrex ACP, and EmCyte Pure PRP systems.
- The PRP/PRF product: When prepared at the point of care from the patient's own blood, minimally manipulated, and used during the same surgical or treatment session, PRP/PRF is generally considered to fall under the practice of medicine rather than FDA drug/biologic regulation.
- 21 CFR Part 1271: The FDA's tissue regulation framework includes exemptions for autologous cells and tissues that are minimally manipulated and used for homologous function. PRP/PRF prepared and used at the point of care generally meets these exemption criteria.
What This Means in Practice
The practical regulatory implications are:
- The FDA does not approve or disapprove of PRP/PRF procedures — it regulates the devices used to prepare them.
- Providers are not required to obtain FDA approval to perform PRP/PRF treatments, but they must use FDA-cleared devices.
- Marketing claims about PRP/PRF are subject to FTC (Federal Trade Commission) oversight — providers cannot make unsupported claims about curing diseases.
- PRP/PRF is not FDA-approved as a drug or biologic for any specific indication (hair loss, osteoarthritis, skin rejuvenation, etc.). It is used under the practice of medicine, at the provider's clinical discretion.
State Regulation
Because PRP/PRF falls primarily under the practice of medicine, state medical boards and health departments are the primary regulators:
- Who can perform: State scope-of-practice laws determine which provider types (MDs, DOs, NPs, PAs, dentists) can perform PRP/PRF procedures. Some states allow registered nurses or medical aestheticians to perform microneedling with PRP under physician supervision; others restrict it to physicians only.
- Facility requirements: States vary in whether PRP/PRF can be performed in medical spas, non-medical spas, dental offices, or only in licensed medical facilities. The VIP Spa case in New Mexico highlighted gaps in state oversight of non-medical facilities offering blood-based procedures.
- Advertising restrictions: State medical boards may restrict claims providers can make about PRP/PRF efficacy.
Insurance and Coding
PRP/PRF procedures are generally not covered by insurance because they lack FDA-approved indications. CPT codes exist for PRP preparation and injection (e.g., CPT 0232T for PRP injection), but most payers consider the procedure experimental or investigational for common applications and deny coverage. Some exceptions may exist for specific orthopedic applications in certain payer contracts.
Further Reading
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Cost
Typical Pricing by Application
| Application | Cost Per Session | Sessions Needed | Estimated First-Year Cost |
|---|---|---|---|
| Facial rejuvenation (Vampire Facial) | $500–$1,000 | 3–4 initial + 1–2 maintenance | $2,000–$5,000 |
| Hair restoration (scalp PRP) | $500–$1,500 | 3–4 initial + 1–2 maintenance | $2,000–$6,000 |
| Knee osteoarthritis (injection) | $500–$1,200 | 1–3 initial; repeat at 6–12 months | $500–$3,600 |
| Tendinopathy (injection) | $500–$1,000 | 1–2 | $500–$2,000 |
| EZ Gel PRF (facial volumizing) | $800–$1,500 | 2–4 initial + maintenance every 3–6 months | $2,400–$6,000 |
| Under-eye PRP/PRF | $500–$900 | 2–3 | $1,000–$2,700 |
What Affects Price
- Geographic location: Major metropolitan areas (New York, Los Angeles, Miami) command premium pricing; smaller markets may be 20–40% less.
- Provider credentials: Board-certified dermatologists and plastic surgeons typically charge more than general practitioners or nurse practitioners.
- PRP system used: FDA-cleared commercial systems (Harvest, EmCyte, Arthrex) may increase procedure costs compared to generic centrifuge systems.
- Combination treatments: PRP with microneedling costs more than PRP injection alone. Adding PRP to a surgical procedure (rotator cuff repair, hair transplant) increases the surgical fee.
- Volume of blood processed: Hair restoration and large-area skin treatments require more blood and more PRP, increasing supply costs.
Insurance Coverage
PRP/PRF treatments are generally not covered by health insurance. Most insurance companies classify PRP as experimental or investigational for all common applications. This applies to both aesthetic uses (skin, hair) and medical uses (osteoarthritis, tendinopathy). All costs are typically out-of-pocket. Some orthopedic providers have had success obtaining coverage on a case-by-case basis for knee osteoarthritis, but this is not standard.
Cost Comparison with Alternatives
| Treatment | Per-Session Cost | Insurance |
|---|---|---|
| PRP facial | $500–$1,000 | Not covered |
| Hyaluronic acid fillers | $600–$1,200/syringe | Not covered |
| Botox | $300–$600/area | Not covered (cosmetic) |
| PRP for hair | $500–$1,500 | Not covered |
| Finasteride (hair loss) | $10–$30/month | Sometimes covered |
| Minoxidil (hair loss) | $15–$50/month | OTC — no Rx needed |
| PRP for knee OA | $500–$1,200 | Rarely covered |
| Hyaluronic acid knee injection | $300–$800 | Often covered |
| Cortisone knee injection | $100–$300 | Usually covered |
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Key Takeaways
Based on the available evidence:
- PRP and PRF are autologous platelet concentrates derived from the patient's own blood. They concentrate growth factors (PDGF, TGF-β, VEGF, EGF, IGF-1) that stimulate tissue healing, collagen production, and angiogenesis.
- PRF differs from PRP in that it uses no anticoagulant and produces a fibrin scaffold for sustained growth factor release (7–14 days) versus PRP's rapid bolus release. EZ Gel PRF further evolves this by adding autologous albumin for a volumizing gel.
- Hair restoration has the strongest clinical evidence, with multiple randomized controlled trials (including Gentile et al., 2015 and Leo et al., 2015) demonstrating increased hair density and thickness compared to placebo.
- Knee osteoarthritis is well-supported by meta-analyses showing PRP superior to hyaluronic acid and corticosteroid injections for pain relief and functional improvement.
- Skin rejuvenation evidence is growing, with Hersant et al. (2021) systematically reviewing PRP's benefit for facial rejuvenation, particularly in combination with microneedling.
- Safety is generally favorable because the material is autologous, eliminating allergy and rejection risks. Side effects are typically mild and localized (pain, swelling, bruising). The 2019 VIP Spa HIV case demonstrated that procedural safety failures — not the therapy itself — pose the real risk.
- The FDA regulates PRP/PRF devices (centrifuges, preparation kits) but does not regulate the procedure itself. PRP/PRF is practiced under state medical board oversight.
- Costs range from $500 to $1,500 per session, with most patients needing 3–4 initial sessions plus maintenance. Insurance generally does not cover these treatments.
Questions to Ask a Provider
- What PRP/PRF preparation system do you use, and is it FDA-cleared?
- How many PRP/PRF procedures have you performed for my specific condition?
- What results can I realistically expect, and what is the evidence for this application?
- How many sessions will I need, and what is the total expected cost?
- What are your infection-control protocols? Do you use single-use equipment for every patient?
- Is PRP or PRF more appropriate for my specific condition?
- Are there conventional treatments I should try first or alongside PRP/PRF?
- What maintenance schedule will be needed to sustain results?
This content is for informational and educational purposes only. It is not intended as, and should not be interpreted as, medical advice. The information provided does not cover all possible uses, precautions, interactions, or adverse effects, and may not reflect the most recent medical research or guidelines. It should not be used as a substitute for the advice of a qualified healthcare professional. Never disregard professional medical advice or delay seeking treatment because of something you have read here. Always speak with your doctor or pharmacist before starting, stopping, or changing any prescribed medication or treatment. If you think you may have a medical emergency, call your doctor or emergency services immediately. GLPbase does not recommend or endorse any specific tests, physicians, products, procedures, or opinions. Use of this information is at your own risk.
Q&A
Myth: PRP is the same as stem cell therapy.
PRP and PRF are not stem cell therapies. They concentrate platelets and growth factors from your own blood — they do not contain stem cells in any meaningful quantity. The growth factors in PRP (PDGF, VEGF, TGF-β) stimulate your body's existing repair mechanisms, but this is fundamentally different from introducing exogenous stem cells. Clinics that market PRP as "stem cell therapy" are misrepresenting the treatment (Chahla et al., 2017).
Myth: All PRP treatments are the same.
PRP preparation varies enormously between clinics and systems. Platelet concentration can range from 2× to 8× baseline depending on the centrifuge system, spin protocol, and preparation technique. Leukocyte content (leukocyte-rich vs. leukocyte-poor PRP) also varies and may affect outcomes depending on the application. There is no universal standardization, which is one reason clinical trial results are inconsistent (Fadadu et al., 2019).
Question: Is PRP or PRF better for hair loss?
Both have shown promise for androgenetic alopecia, but head-to-head comparisons are limited. PRF theoretically offers advantages — its fibrin matrix provides sustained growth factor release over 7–14 days compared to PRP's immediate release. Some practitioners report better patient satisfaction with PRF for hair, but the clinical evidence base is larger for PRP, with multiple randomized controlled trials demonstrating increased hair density and thickness (Evans et al., 2020).
Question: How many PRP sessions are needed to see results?
Most clinical protocols use 3–4 sessions spaced 4–6 weeks apart for initial treatment, followed by maintenance sessions every 6–12 months. For hair loss, measurable improvements in hair count and thickness are typically reported after 3–6 months. For skin rejuvenation, improvements in texture and tone may be visible after 2–3 sessions. For orthopedic applications (knee osteoarthritis), some studies show benefit after a single injection, but protocols vary.
Question: Is PRP covered by insurance?
In most cases, no. PRP is generally considered an elective or experimental procedure by insurance companies. Orthopedic applications (particularly for knee osteoarthritis) have the strongest case for coverage, but most insurers still classify PRP as investigational. Costs typically range from $500–$1,500 per session out of pocket.
Myth: PRP is risk-free because it uses your own blood.
While PRP has a favorable safety profile and allergic reactions are essentially eliminated since it's autologous (from your own blood), it is not risk-free. Potential side effects include pain at the injection site, infection (any time a needle breaks the skin), nerve injury (particularly in joint injections), and temporary swelling or bruising. Serious complications are rare but have been reported, particularly with inexperienced practitioners or non-sterile preparation.
Question: Can PRP be combined with other treatments?
Yes — PRP is frequently combined with microneedling for skin rejuvenation (the "vampire facial"), with hair transplant surgery to improve graft survival, and with hyaluronic acid injections for joint applications. Some practitioners combine PRP with exosome therapies, though evidence for combination protocols is still limited. The safety of combinations appears acceptable based on published case series, but optimal protocols have not been established through rigorous trials.
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.
Sources & Further Reading
Foundational & Comprehensive Reviews
- Marx RE (2004) — "Platelet-Rich Plasma: Evidence to Support Its Use" — Journal of Oral and Maxillofacial Surgery
- Choukroun J et al. (2006) — "Platelet-Rich Fibrin (PRF): A Second-Generation Platelet Concentrate" — Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
- Dhurat R, Sukesh M (2014) — "Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective" — Indian Journal of Dermatology
Hair Restoration
- Gentile P et al. (2015) — "The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial" — Stem Cells Translational Medicine
- Leo MS et al. (2015) — "Systematic Review of the Use of Platelet-Rich Plasma in Androgenetic Alopecia" — Dermatologic Surgery
Skin Rejuvenation
Orthopedic Applications
- Riboh JC et al. (2016) — "Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis" — American Journal of Sports Medicine
- Mishra A, Pavelko T (2006) — "Treatment of Chronic Elbow Tendinosis with Buffered Platelet-Rich Plasma" — American Journal of Sports Medicine
Safety & Regulatory
- CDC MMWR (2020) — "HIV Diagnoses After Receipt of Platelet-Rich Plasma Facials at an Unlicensed Facility — New Mexico"
- FDA — Tissue & Tissue Products Regulation (21 CFR 1271)
- FDA — Medical Devices (PRP centrifuge and kit clearances)
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider.